News Chart Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2024 BST			5-day change	1st Jan Change
7.83 ^USD	+2.09%		+14.47%	-12.90%

05-15	Transcript : Travere Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
05-07	Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating	MT

46210d1b65596e8da208321e5f5c3f15.H46epjZ7FDAkplVfKaJUGAEfHso_1ODMZZi6m6LcW90.U-bu7X5JLUVT7hMvG8ljQTBYSb1bsridE_HgzerxDbBt4P_SUhF6X1ORNg~a741600d9d404e815615083c1e4e51ec